<DOC>
	<DOCNO>NCT00821847</DOCNO>
	<brief_summary>Recent progress antiretroviral therapy turn HIV infection chronic disease . Patients survival dramatically improve complication may occur need prevent monitor . As much 10 % HIV patient may suffer chronic kidney disease , affection symptomatic late stage secondary HIV infection , drug exposure , hypertension diabetes . Guidelines suggest renal function regularly assess HIV patient perform early diagnosis chronic kidney disease allow initiation preventive measure aim preserve renal function . Plasma creatinine dosage easy way evaluate renal function glomerular filtration rate estimation cockcroft MDRD formulae much good indicator renal function . Other marker like cystatin C may use . None marker validate HIV patient . Therefore study aim compare validity creatinine clearance estimation Cockcroft Gault MDRD formula cystatin C compare gold standard measurement glomerular renal function .</brief_summary>
	<brief_title>Renal Function Assessment HIV Patient</brief_title>
	<detailed_description>Aim study : The aim study test different available marker estimation glomerular filtration rate ( GFR ) HIV patient order determine one appropriate particular population . We analyze role variation muscular mass estimation GFR Background : Several line evidence point renal disease become important complication human immunodeficiency virus infection therapy . The spectrum renal disease HIV patient dramatically change HIV associate nephropathy become less prevalent chronic kidney disease [ CKD ] become everyday concern parallel prevalence renal risk factor age , hypertension diabetes . Different study show prevalence CKD define estimate glomerular filtration rate 60 ml/min/1.73m2 around 10 % HIV patient . CKD associate increased mortality , new concept emerge past year put CKD top 5 critical cardiovascular risk factor . Evaluating individual renal function HIV patient allow good care prevention cardiovascular event well initiation nephro-protection strategy order slow loss renal function alleviate postpone need dialysis . Since HIV patient also receive chronic multi-therapy , evaluate renal function also mandatory allow drug dosage adaptation . Plasma creatinine dosage routinely used estimate GFR closely correlate age , sex , weight ethnic origin patient . All factor make creatinine unreliable GFR estimation . Laboratory dosage creatinine may perform different technique ( JAFFE enzymatic dosage ) 20 % variation result patient . None GFR estimation formula ( Cockcroft et Gault MDRD ) validate HIV patient . Cystatin C , new marker still evaluation , seem show interest patient relative independency regard muscle mass , test HIV patient . Some cystatin C base formula propose yet test validated HIV patient . HIV infect patient may exhibit abnormal body composition particularly affect lipid also , show recently , muscle mass . Our study precisely measure body composition order allow interpretation variation renal marker regard muscle mass . METHODS : 60 patient ( men , caucasian ) estimate GFR 60 15 ml/min/1.73m2 include study . After give necessary information collection inform consent , blood drown allow creatinine , cystatin C , albumin , C reactive protein urea dosage . GFR measure use plasmatic clearance EDTA-51Cr . Body composition perform use DEXA scan . Two visit necessary complete evaluation every patient , schedule time routine medical visit . Expected result : Our study allow good definition ideal marker GFR HIV infect male . Il also afford good comprehension factor involve variation creatinine dosage population namely related biochemical dosage change body composition . Conclusion : HIV infection treatment definitely serious risk factor renal disease . Although , optimal care HIV-infected patient become complex due multiple comorbidities , effort must make diagnose decline glomerular filtration rate order provide improve control CKD-associated cardiovascular risk optimize antiretroviral therapy . Therefore evaluate glomerular filtration rate critical HIV-infected patient allow determination optimum follow strategy critical therapeutic measure , namely drug dosage adaptation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Inclusion criterion : 18 Years old Patients must detectable HIV1 westernblot consent signature Estimated glomerular filtration rate , Modification Diet Renal Disease ( MDRD ) Cockcroft equation , 30 60 ml/min/1.73m2 Male Caucasian Patient provide informed consent Patient able respect protocol social security affiliation Exclusion criterion : acute renal failure dysthyroidal function metallic prosthesis unable understand inform consent document venous puncture impossible receive steroid possible follow</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>HIV</keyword>
	<keyword>glomerular filtration rate</keyword>
	<keyword>cockcroft</keyword>
	<keyword>MDRD formula</keyword>
	<keyword>creatinine</keyword>
	<keyword>cystatin C</keyword>
	<keyword>isotopic clearance</keyword>
	<keyword>EDTA-51Cr</keyword>
	<keyword>DEXA scan</keyword>
</DOC>